Similar Search Results

The ethics of insurance industry step therapy policies : a medical profession ethics approach

Santoro, Michael A. - In: Business & professional ethics journal 38 (2019) 3, pp. 339-351

Persistent link: https://www.econbiz.de/10012126256

What effect did Medicare Part D have on SSDI medicare beneficiaries? : a look at prescription drug coverage, utilization, and expenditures

Alfrey, Brett - In: American Journal of Health Economics : AJHE official … 10 (2024) 3, pp. 437-469

Persistent link: https://www.econbiz.de/10014633598

Cheap exclusion in markets with multiple complements

O'Brien, Daniel P.; Israel, Mark; Benton, Erica - In: International journal of industrial organization 89 (2023), pp. 1-16

Persistent link: https://www.econbiz.de/10014546210

Physician responses to insurance benefit restrictions : the case of ophthalmology

Abiona, Olukorede; Haywood, Phil; Yu, Serena; Hall, Jane; … - In: Health economics 33 (2024) 5, pp. 911-928

Persistent link: https://www.econbiz.de/10014514601

The impact of a national formulary expansion on diabetics

McNamara, Cici; Serna, Natalia - In: Health economics 31 (2022) 11, pp. 2311-2332

Persistent link: https://www.econbiz.de/10013461821

Does the legalisation of cannabis for medicinal use impact private health insurer prescription drug expenditures?

Cook, Amanda C.; Sirmans, E. Tice; Wells, Brenda - In: The Geneva papers on risk and insurance - issues and … 49 (2024) 1, pp. 212-226

Persistent link: https://www.econbiz.de/10014446859

Moral hazard in drug purchases

Verho, Jouko; Harju, Jarkko - 2023

We study the moral hazard effects of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out-of-pocket drug costs decrease substantially. Our results...

Persistent link: https://www.econbiz.de/10014289803